These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 24125682
1. [Relationship between chemokine axis CXCL12-CXCR4 and epithelial ovarian cancer]. Guo Q, Wu XH, Lü YP, Yang B, Xu F, Zhang SJ. Zhonghua Yi Xue Za Zhi; 2013 Jun 04; 93(21):1677-80. PubMed ID: 24125682 [Abstract] [Full Text] [Related]
2. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention. Zheng N, Chen J, Li T, Liu W, Liu J, Chen H, Wang J, Jia L. Mol Carcinog; 2017 Aug 04; 56(8):1896-1908. PubMed ID: 28277622 [Abstract] [Full Text] [Related]
3. CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer. Guo Q, Gao BL, Zhang XJ, Liu GC, Xu F, Fan QY, Zhang SJ, Yang B, Wu XH. Oncol Res; 2014 Aug 04; 22(5-6):247-58. PubMed ID: 26629936 [Abstract] [Full Text] [Related]
4. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells]. Jiang YP, Wu XH, Xing HY, DU XY. Zhonghua Fu Chan Ke Za Zhi; 2007 Jun 04; 42(6):403-7. PubMed ID: 17697603 [Abstract] [Full Text] [Related]
5. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer. Zheng N, Liu W, Chen J, Li B, Liu J, Wang J, Gao Y, Shao J, Jia L. Mol Carcinog; 2019 Jan 04; 58(1):144-155. PubMed ID: 30259564 [Abstract] [Full Text] [Related]
6. Role of CXCL12 in metastasis of human ovarian cancer. Jiang YP, Wu XH, Xing HY, DU XY. Chin Med J (Engl); 2007 Jul 20; 120(14):1251-5. PubMed ID: 17697577 [Abstract] [Full Text] [Related]
7. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro. Liu Y, Ren CC, Yang L, Xu YM, Chen YN. J Cell Physiol; 2019 Apr 20; 234(4):3897-3909. PubMed ID: 30191987 [Abstract] [Full Text] [Related]
9. Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer. Mao TL, Fan KF, Liu CL. Gene Ther; 2017 Oct 20; 24(10):621-629. PubMed ID: 28753202 [Abstract] [Full Text] [Related]
10. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer. Xue J, Li R, Gao D, Chen F, Xie H. Int J Nanomedicine; 2020 Oct 20; 15():5701-5718. PubMed ID: 32848392 [Abstract] [Full Text] [Related]
11. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F. Int J Cancer; 2008 Jan 01; 122(1):91-9. PubMed ID: 17893878 [Abstract] [Full Text] [Related]
13. Fusion-derived epithelial cancer cells express hematopoietic markers and contribute to stem cell and migratory phenotype in ovarian carcinoma. Ramakrishnan M, Mathur SR, Mukhopadhyay A. Cancer Res; 2013 Sep 01; 73(17):5360-70. PubMed ID: 23856249 [Abstract] [Full Text] [Related]
16. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR. Cancer Res; 2002 Oct 15; 62(20):5930-8. PubMed ID: 12384559 [Abstract] [Full Text] [Related]
18. Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy. Salomonnson E, Stacer AC, Ehrlich A, Luker KE, Luker GD. PLoS One; 2013 Oct 15; 8(1):e51500. PubMed ID: 23372646 [Abstract] [Full Text] [Related]
19. [Effect of stromal cell-derived factor-1 and its receptor CXCR4 on liver metastasis of human colon cancer]. Ding YL, Fu QY, Tang SF, Zhang JL, Li ZY, Li ZT. Zhonghua Wai Ke Za Zhi; 2009 Feb 01; 47(3):210-3. PubMed ID: 19563077 [Abstract] [Full Text] [Related]